Related content

Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment

By Ingelman-Sundberg M.   Oscarson M.   McLellan R.A.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 8, 1999-08 ,pp. : 342-349

Elsevier

Access to resources Recommend Favorite

Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism

By Porcelli Stefano   Fabbri Chiara   Spina Edoardo   Serretti Alessandro   De Ronchi Diana  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 9, 2011-09 ,pp. : 1101-1115

Informa Healthcare

Access to resources Recommend Favorite

Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery

By Gelboin H.V.   Krausz K.W.   Gonzalez F.J.   Yang T.J.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 11, 1999-11 ,pp. : 432-438

Elsevier

Access to resources Recommend Favorite

Expression, Function and Regulation of Mouse Cytochrome P450 Enzymes: Comparison With Human Cytochrome P450 Enzymes

By  

Current Drug Metabolism, Vol. 10, Iss. 10, 2009-12 ,pp. : 1151-1183

Bentham Science Publishers

Access to resources Recommend Favorite

Cytochrome P450 polymorphisms and drug-induced interstitial lung disease

By Schwaiblmair Martin   Behr Werner   Foerg Wolfgang   Berghaus Thomas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1547-1560

Informa Healthcare

Access to resources Recommend Favorite